Innate Pharma has completed a EUR 33.7m capital increase on Euronext Paris' compartment C. The instiutional tranche was reportedly 2.5x over-subscribed. Bryan Garnier was joint lead manager and joint bookrunner on this transaction alongside Société Générale.
Company has raised €20m so far over two funding rounds
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy